Literature DB >> 9372724

Association of pseudoexfoliation syndrome with increased vascular risk.

P Mitchell1, J J Wang, W Smith.   

Abstract

PURPOSE: To examine vascular associations with pseudoexfoliation syndrome in view of the wide-spread elastosis now demonstrated in this disorder that affects many tissues, including vessel walls.
METHODS: The Blue Mountains Eye Study is a population-based study of eye disease in an area west of Sydney, Australia. Of 4433 eligible persons aged 49 years or older, 3,654 (82.4%) participated. Signs of pseudoexfoliation were graded clinically, after excluding 108 people who had bilateral cataract surgery.
RESULTS: Pseudoexfoliation was present in 81 (2.3%) of 3546 participants aged 49 years or older. The prevalence of pseudoexfoliation increased with age and was higher in women and in people with glaucoma. Pseudoexfoliation was statistically significantly associated with a history of angina or hypertension or a combined history of angina, acute myocardial infarction, or stroke.
CONCLUSION: Slit-lamp signs of pseudoexfoliation may identify individuals with an increased vascular risk.

Entities:  

Mesh:

Year:  1997        PMID: 9372724     DOI: 10.1016/s0002-9394(14)70908-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  90 in total

1.  Hemodynamic evaluation of the posterior ciliary circulation in exfoliation syndrome and exfoliation glaucoma.

Authors:  Efstathios T Detorakis; Athanassios K Achtaropoulos; Eleni E Drakonaki; Vassilios P Kozobolis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-17       Impact factor: 3.117

2.  Combined exfoliation and pigment dispersion: an overlap syndrome.

Authors:  R Mudumbai; J M Liebmann; R Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  1999

3.  Cerebrovascular blood flow velocities in pseudoexfoliation.

Authors:  Nurşen Yüksel; Yonca Anik; Aysun Kiliç; Vlevent Karabaş; Ali Demirci; Yusuf Cağlar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-13       Impact factor: 3.117

4.  Electroneuromyographic findings in pseudoexfoliation syndrome.

Authors:  Deniz Turgut Coban; Tuncay Cakir; Muhammet Kazim Erol; Gulsum Dogan; Berna Dogan; Meral Bilgilisoy Filiz; Naciye Fusun Toraman
Journal:  Int Ophthalmol       Date:  2017-04-12       Impact factor: 2.031

5.  Exfoliation and carotid stiffness.

Authors:  M Irkec
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

Review 6.  The medical and surgical management of pseudoexfoliation glaucoma.

Authors:  Manishi A Desai; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2008

7.  Pseudoexfoliation syndrome: analysis of systemic comorbidities of 325 PEX-positive patients compared with 911 PEX-negative patients.

Authors:  Elizabeth Scharfenberg; Franziska G Rauscher; Petra Meier; Dirk Hasenclever
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-16       Impact factor: 3.117

8.  YKL-40 is a local marker for inflammation in patients with pseudoexfoliation syndrome.

Authors:  Tansu Gonen; Savas Guzel; Kadircan H Keskinbora
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

9.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

10.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.